Research

Scientific research is the basis for understanding the causes, development and treatment of neurological diseases. At the National Institute for Neurological Research (NEUR-IN), we bring together leading-edge facilities and experts from 11 research centres across the country.

Publications

2025

A novel Azaspirooxindolinone-based PROTAC for selective BTK degradation and enhanced anticancer activity.

NK Rampeesa, R Gundla, G Muddasani, S Tangallapalli, S Anugu, S Gurská, JB De Sanctis, P Džubák, M Hajdúch, V Das
Bio Chem (2025) 157, 108316
2025

Antineoplastics for treating Alzheimer’s disease and dementia: Evidence from preclinical and observational studies.

V Das, JH Miller, CG Alladi, N Annadurai, JB De Sanctis, L Hrubá, M Hajdúch
Med Res Rev (2024) 44, 2078–2111
2025

Early functional changes in lewy body dementia: roles of dynamics, locus coeruleus, and compensation.

Mitterová, K., Výtvarová, E., Kovářová, A., Lamoš, M., Fousek, J., & Rektorová, I.
Alzheimer's Research & Therapy, 17, 199.
2025

Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond.

JV Garmendia, CV De Sanctis, V Das, N Annadurai, M Hajdúch, JB De Sanctis
Curr Neuropharmacol (2023) 22, 1080–1109. 
2025

Structural and functional insights into the selective inhibition of mutant tau aggregation by purpurin and oleocanthal in frontotemporal dementia.

AC Goud, I Kozlov, P Skoupilová, L Malina, S Roy, V Das
Protein Sci (2025).

NESPI

National Expert Group for Innovative Treatment of Neurological Diseases.

NESPI was established within the National Institute for Neurological Research (NEUR-IN). This group consists of leading Czech experts from various fields. From physicians and researchers to specialists in legislation, ethics and economics. Together they focus on modern approaches to the treatment of neurological diseases. Their work contributes not only to the availability and safety of innovative treatments in the Czech Republic, but also to their ethical and transparent implementation in practice.